Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02068820 · ClinicalTrials.gov registry record · NA
Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT02068820 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 200 participants.
The verdict
NCT02068820, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The investigators hypothesis is that if sensitivity and specificity are found to be significantly higher than the current reports with Technesium-99 and ISB colorimetric dye, SLN biopsies might allow omission of full lymphadenectomy in lower-risk cases, thereby limiting peri-operative morbidity. SLN biopsies might also improve the detection of metastatic disease, essentially lowering the recognized false-negative rate of standard lymphadenectomy analyzed by routine H\&E pathologic analysis.
Interventions
- DEVICE ISB dye and standard white light imaging
- DEVICE ICG dye and FireFly fluorescence imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2012-09 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02068820
The ClinicalTrials.gov registry entry for NCT02068820 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ISB dye and standard white light imaging is the first listed.
NCT02068820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02068820 about?
NCT02068820 is a clinical study titled "Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG". The investigators hypothesis is that if sensitivity and specificity are found to be significantly higher than the current reports with Technesium-99 and ISB colorimetric dye, SLN biopsies might allow omission of full lymphadenectomy in lower-risk cases, thereby limiting peri-operative morbidity. SLN...
What is the current status of trial NCT02068820?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2012-09. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02068820?
The interventions under investigation include: ISB dye and standard white light imaging (DEVICE), ICG dye and FireFly fluorescence imaging (DEVICE).
Who is sponsoring clinical trial NCT02068820?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.